MedTrace Logo

Impact of Lactoferrin, a Dietary Supplement, vs. Placebo on Respiratory Tract Infections

NCT04713735 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 76

Last updated 2023-10-18

No results posted yet for this study

Summary

This is a randomized, double-blind, placebo-controlled study to evaluate the impact of bovine Lactoferrin (bLf) on respiratory tract infections (RTIs) in an elderly population in the United States.

Conditions

  • Immune Health

Interventions

DIETARY_SUPPLEMENT

Control: Placebo

Placebo

DIETARY_SUPPLEMENT

bovine lactoferrin supplement

600 mg

Sponsors & Collaborators

  • Mead Johnson Nutrition

    lead INDUSTRY

Principal Investigators

  • Steven Wu, MD · Mead Johnson/RB

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-02-08
Primary Completion
2022-02-28
Completion
2023-04-28

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04713735 on ClinicalTrials.gov